Lu Gan
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Drug Transport and Resistance Mechanisms
- Chemokine receptors and signaling
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 9
- Colorectal Cancer Treatments and Studies 3
- Cancer Cells and Metastasis 3
- CAR-T cell therapy research 3
- Drug Transport and Resistance Mechanisms 3
- Chemokine receptors and signaling 3
- Immunology 10
- Immunotherapy and Immune Responses 5
- Co-authors
- Patrick Augustijns (1 shared paper)Dhiren R. Thakker (1 shared paper)M. Arthur Moseley (1 shared paper)R. Wayne Hendren (1 shared paper)Jerold S. Harmatz (2 shared papers)David J. Greenblatt (2 shared papers)Bryan Laffitte (1 shared paper)Lisa L. von Moltke (1 shared paper)
- Journals
- Medicine (2 papers)Annals of Oncology (2 papers)Journal of Clinical Oncology (2 papers)Drug Metabolism and Disposition (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesChinaThailand
In The Last Decade
Lu Gan
23 papers receiving 379 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 87
- Oncology 229
- Transplantation 12
- Hepatology 30
- Pediatrics, Perinatology and Child Health 71
Countries citing papers authored by Lu Gan
This map shows the geographic impact of Lu Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Gan more than expected).
Fields of papers citing papers by Lu Gan
This network shows the impact of papers produced by Lu Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Gan. The network helps show where Lu Gan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Gan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 127 | |
| 2 | 2019 | 59 | |
| 3 | 2008 | 34 | |
| 4 | 2021 | 34 | |
| 5 | 2005 | 22 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 15 | |
| 8 | 2018 | 10 | |
| 9 | 2018 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2019 | 8 | |
| 12 | 2021 | 6 | |
| 13 | 2018 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2018 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2017 | 2 | |
| 20 | 2020 | 1 |
About Lu Gan
Lu Gan is a scholar working on Oncology, Immunology, Molecular Biology, Epidemiology and Dermatology, having authored 27 papers that have together received 385 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Cells and Metastasis (3 papers), CAR-T cell therapy research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Chemokine receptors and signaling (3 papers) and TGF-β signaling in diseases (2 papers). The work is most often cited by research in Pharmacology (87 citations), Oncology (229 citations), Transplantation (12 citations), Hepatology (30 citations) and Pediatrics, Perinatology and Child Health (71 citations). Lu Gan has collaborated with scholars based in United States, China and Thailand. Frequent co-authors include Patrick Augustijns, Dhiren R. Thakker, M. Arthur Moseley, R. Wayne Hendren, Jerold S. Harmatz, David J. Greenblatt, Bryan Laffitte, Lisa L. von Moltke, Jie Zhang and Michael H. Court. Their work appears in journals such as Medicine, Annals of Oncology, Journal of Clinical Oncology, Drug Metabolism and Disposition and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.